Children on antidepressants receive less monitoring during the first 2 months of treatment than recommended by the FDA, researchers said. Study data showed children and adolescents were monitored less than three times per month on average; the FDA recommends four times per month, to watch for an increased risk for suicidality.

Related Summaries